McKesson Snags Precision Medicine Group In $2.25B Deal
By Jade Martinez-Pogue · August 25, 2026, 4:21 PM EDT
Healthcare services provider McKesson Corp., advised by Davis Polk & Wardwell LLP, on Tuesday unveiled plans to acquire clinical research and biopharmaceutical commercialization services business Precision Medicine Group for roughly $2.25...
To view the full article, register now.